XML 48 R14.htm IDEA: XBRL DOCUMENT v3.19.3
Stock-Based Compensation
9 Months Ended
Sep. 30, 2019
Share-based Payment Arrangement [Abstract]  
Stock-Based Compensation

Note 8 – Stock-Based Compensation 

 

In addition to cash compensation, the Company may compensate certain service providers, including employees, directors, consultants, and other advisors, with equity-based compensation in the form of stock options and restricted stock awards.  The Company recognizes all equity-based compensation as stock-based compensation expense based on the fair value of the compensation measured at the grant date. For stock options, fair value is calculated at the date of grant using the Black-Scholes-Merton option pricing model.  For restricted stock awards, fair value is the closing stock price for the Company’s common stock on the grant date. The expense is recognized over the vesting period of the grant.  For the periods presented, all stock-based compensation expense was classified as a component within selling, general and administrative expense in the Company’s consolidated statements of operations.

 

The amount of stock-based compensation expense is as follows:

  

    Three months ended September 30,     Nine months ended September 30,  
    2019     2018     2019     2018  
Stock options   $ 33,975     $ 28,445     $ 113,857     $ 64,820  
Restricted stock awards     2,697       16,773       14,613       60,419  
Total   $ 36,672     $ 45,218     $ 128,470     $ 125,239  

  

During three months ended March 31, 2018, the Company awarded stock options to purchase 25,000 shares of the Company’s common stock at an exercise price of $2.55 per share to one of our business consultants. During the three months ended September 30, 2019, the Company awarded stock options to purchase 10,000 shares of the Company’s common stock at an exercise price of $1.71 per share to the members on the Company’s Board of Directors.  No other stock options were awarded during the nine months ended September 30, 2019.

 

The Company estimated the fair value of stock options using the Black-Scholes-Merton option pricing model with the following assumptions:

  

    Nine months ended September 30,  
    2019     2018  
Number of options awarded to purchase common shares     10,000       105,750  
Risk-free interest rate     1.50%       2.6% - 2.8%  
Expected volatility     100.3%       149.3 - 154.3%  
Assumed dividend yield     N/A       N/A  
Expected life of options from the date of grant     9.8 years       9.8 years  

  

The estimated unrecognized compensation cost from unvested awards which will be recognized ratably over the remaining vesting phase is as follows:

  

Years ended December 31st:     Unvested stock options     Unvested restricted stock awards     Total unrecognized compensation expense  
2019 (remaining three months)       36,909       1,061       37,970  
2020       113,378       4,251       117,629  
2021       70,896       706       71,602  
2022       3,722             3,722  
      $ 224,905     $ 6,018     $ 230,923  

  

Equity Incentive Plans

 

Our 2016 Equity Incentive Plan (the “Equity Incentive Plan”) provides for the issuance of stock-based awards to employees, officers, directors and consultants. The Plan permits the granting of stock awards and stock options.  The vesting of stock-based awards is generally subject to the passage of time and continued employment through the vesting period.

 

Stock Option Activity

 

Stock option activity under our Equity Incentive Plan is summarized as follows:

  

                        Weighted avg.        
            Weighted avg.     Weighted avg.     remaining        
      Number of     exercise price     grant date fair     contractual life     Aggregate  
      awards     per share     value per share     (in years)     intrinsic value  
                                 
Outstanding, December 31, 2018       434,451     $ 1.49     $ 1.47       6.91     $ 230,039  
Granted       10,000     $ 1.53     $ 1.71       10.00     $  
Exercised           $     $           $  
Expired/Forfeited       (7,325 )   $ 1.83     $ 1.86           $  
Outstanding, September 30, 2019       437,126     $ 1.46     $ 1.49       6.23     $ 148,775  
Exercisable, September 30, 2019       256,919     $ 1.21     $ 1.22       4.43     $ 148,775  
Unvested, September 30, 2019       180,207     $ 1.81     $ 1.88       8.78     $  

  

The aggregate intrinsic value represents the total pre-tax intrinsic value (the aggregate difference between the closing price of our common stock on September 30, 2019 and the exercise price for the in-the-money options) that would have been received by the option holders if all the in-the-money options had been exercised on September 30, 2019.

 

Restricted Stock Activity

 

Restricted stock activity under our Equity Incentive Plan is summarized as follows:

  

            Weighted avg.  
      Number of     grant date  
      options     fair value  
Non-vested restricted shares, December 31, 2018       30,000     $ 2.38  
Granted           $  
Vested       (25,000 )   $ 2.35  
Forfeited           $  
Non-vested restricted shares, September 30, 2019       5,000     $ 2.55